AI-Native Screener
Describe the stocks you want in your own words and QuoTrend builds the screen, or filter thousands of US stocks and ETFs across 170+ criteria.
We use strictly necessary cookies to run QuoTrend (authentication, session, security). With your consent, we may also use analytics + marketing cookies to improve the product. You can accept all, reject all non-essential, or pick categories. Read our Privacy Policy.
| No. | Ticker▲ | QT Score | Company | Sector | Industry | Country | Market Cap | P/E | Price | Change | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 161 | PRAX | 61 | Praxis Precision Medicines, Inc. | Healthcare | Biotechnology | USA | 7.71B | - | 285.48 | 6.69% | 382,296 |
| 162 | PRME | 48 | Prime Medicine, Inc. | Healthcare | Biotechnology | USA | 794.74M | - | 5.36 | 23.22% | 8,810,312 |
| 163 | PROK | 15 | ProKidney Corp. | Healthcare | Biotechnology | USA | 219.29M | - | 1.52 | 0.00% | 1,361,641 |
| 164 | PRTA | 35 | Prothena Corporation plc | Healthcare | Biotechnology | Ireland | 452.28M | - | 9.10 | 3.29% | 654,349 |
| 165 | PTCT | 34 | PTC Therapeutics, Inc. | Healthcare | Biotechnology | USA | 5.14B | - | 63.02 | 1.50% | 1,114,121 |
| 166 | PTGX | 65 | Protagonist Therapeutics, Inc. | Healthcare | Biotechnology | USA | 9.14B | 137.09 | 142.14 | 0.72% | 865,918 |
| 167 | PVLA | 78 | Palvella Therapeutics, Inc. | Healthcare | Biotechnology | USA | 1.93B | - | 147.47 | 10.95% | 178,757 |
| 168 | QURE | 14 | uniQure N.V. | Healthcare | Biotechnology | Netherlands | 1.66B | - | 24.97 | 2.84% | 1,571,066 |
| 169 | RAPP | 19 | Rapport Therapeutics, Inc. Common Stock | Healthcare | Biotechnology | USA | 1.14B | - | 22.50 | -18.30% | 601,911 |
| 170 | RARE | 29 | Ultragenyx Pharmaceutical Inc. | Healthcare | Biotechnology | USA | 1.65B | - | 17.20 | 2.69% | 4,943,979 |
| 171 | RCUS | 22 | Arcus Biosciences, Inc. | Healthcare | Biotechnology | USA | 2.25B | - | 18.39 | 1.38% | 2,231,835 |
| 172 | REGN | 74 | Regeneron Pharmaceuticals, Inc. | Healthcare | Biotechnology | USA | 83.09B | 19.96 | 813.27 | -0.35% | 693,077 |
| 173 | REPL | 92 | Replimune Group, Inc. | Healthcare | Biotechnology | USA | 1.19B | - | 16.06 | 23.07% | 4,297,897 |
| 174 | RGNX | 29 | REGENXBIO Inc. | Healthcare | Biotechnology | USA | 433.05M | - | 7.24 | 9.70% | 1,220,877 |
| 175 | RIGL | 90 | Rigel Pharmaceuticals, Inc. | Healthcare | Biotechnology | USA | 939.78M | 3.08 | 50.74 | 0.38% | 133,065 |
| 176 | RLAY | 59 | Relay Therapeutics, Inc. | Healthcare | Biotechnology | USA | 4.12B | - | 19.69 | 4.51% | 2,258,100 |
| 177 | RLMD | 26 | Relmada Therapeutics, Inc. | Healthcare | Biotechnology | USA | 342.41M | - | 3.35 | 4.36% | 1,673,656 |
| 178 | ROIV | 56 | Roivant Sciences Ltd. | Healthcare | Biotechnology | United Kingdom | 26.24B | - | 37.11 | 1.56% | 6,561,784 |
| 179 | RVMD | 90 | Revolution Medicines, Inc. | Healthcare | Biotechnology | USA | 39.74B | - | 188.72 | 1.34% | 1,171,141 |
| 180 | RXRX | 49 | Recursion Pharmaceuticals, Inc. | Healthcare | Biotechnology | USA | 2.23B | - | 4.35 | 7.41% | 22,100,545 |